Sansum Diabetes Research Institute
CLINICAL TRIALS
CURRENT ADULT STUDIES
Supervised Safety and Feasibility Evaluation of Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
The International Diabetes Closed Loop (iDCL) Trial: Protocol 4 (DCLP4)
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients With Type 1 Diabetes
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
A Randomized Crossover Comparison of Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) with Different Stress Assessments in the Outpatient Setting for Patients with Type 1 Diabetes
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
Comparison of Insulin Degludec with Insulin Glargine U100 for adults with type 1 diabetes traveling across multiple time zones. A pilot study.
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
Dexcom Continuous Monitoring and Control of Hypoglycemia (COACH)
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
Abbott Sensor Based Glucose Monitoring System Characterization Study using Capillary Glucose Reference.
Subjects must be: At least 18 years of age; require insulin therapy through an insulin pump and/or multiple daily injections (at least 3 injections daily), and be able to commit to 21 days participation.
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
YSI Feasibility Study of the Dexcom® Continuous Glucose Monitoring (CGM) System in Adults and Pediatrics with Diabetes Mellitus.
Must be: Ages 6 years or older, Diagnosed with Type 1 or Type 2 Diabetes Mellitus
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
CURRENT PEDIATRIC STUDIES
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
Freestyle Libre Flash Glucose Monitoring System Pediatric Accuracy Study
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
Freestyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
Dexcom Continuous Monitoring and Control of Hypoglycemia (COACH)
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations.
Must be: 6-17 years of age and weigh at least 57.2 pounds.
Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640
CURRENT PREGNANCY STUDIES
Supervised Safety and Feasibility Evaluation of Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy (LOIS-P)
Evaluating the safety and accuracy of CGM in pregnancy. These research projects include an in-clinic portion and will have standard subject reimbursement. Principal Investigators: Kristin Castorino, DO and Jordan Pinsker, MD
Please contact Dr. Jordan Pinsker for more information, jpinsker@sansum.org or call 805-682-7640 ext 257
CGM Accuracy in Pregnancy Research
Who: Pregnant women with any type of diabetes
When: Open Enrollment
Duration: Approximately 2 weeks
Please contact Kristen Nelson for more information, knelson@sansum.org or call 805-682-7640 ext. 252
GDM Prevention Study
We are a clinical site for CalPoly Stride Program’s GDM Prevention study. The gestational diabetes prevention program is studying whether weight loss before your next pregnancy can help prevent gestational diabetes from happening again. Principal Investigator: Suzanne Phelan, PhD
Who: Postpartum women with history of GDM who might have another baby
When: Open Enrollment
Duration: Approx 12 week intervention with follow-up if you become pregnant
Please contact Kristen Nelson for more information, knelson@sansum.org or call 805-682-7640 ext. 252
GET IN TOUCH
FIND US
2219 Bath Street
Santa Barbara, CA 93105
CALL
Telephone: 805.682.7638
Fax: 805.682.3332
Patient Care: 805.682.4793
CONTACT SDRI
